Evidence map›Paper›PMID 24497844›Full record

ArticlePLoS genetics2014

High risk population isolate reveals low frequency variants predisposing to intracranial aneurysms.

Mitja I Kurki, Emília Ilona Gaál, Johannes Kettunen, Tuuli Lappalainen, Androniki Menelaou, Verneri Anttila, Femke N G van 't Hof, Mikael von Und Zu Fraunberg, Seppo Helisalmi, Mikko Hiltunen and 25 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
6.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Epigenetic mechanisms in aneurysm formation, growth, and rupture: A systematic review.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Rho Guanine Nucleotide Exchange FactorCirculation. Genomic and precision medicine · 2018
    Article
  17. Rare and Low-Frequency Variant ofCirculation. Genomic and precision medicine · 2018
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors at 14 institutions in 6 countries.

Mitja I KurkiNeurosurgery, NeuroCenter, Kuopio University Hospital, Kuopio, Finland ; Neurosurgery, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland ; Department of Neurobiology, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Emília Ilona GaálDepartment of Neurosurgery, Helsinki University Central Hospital, Helsinki, Finland.
Johannes KettunenInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland ; Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland.
Tuuli LappalainenDepartment of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland.
Androniki MenelaouDepartment of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
Verneri AnttilaInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland ; Analytical and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America ; Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America.
Femke N G van 't HofUMC Utrecht Stroke Center, Department of Neurology and Neurosurgery, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, The Netherlands.
Mikael von Und Zu FraunbergNeurosurgery, NeuroCenter, Kuopio University Hospital, Kuopio, Finland ; Neurosurgery, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
Seppo HelisalmiNeurology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
Mikko HiltunenNeurology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
Hanna LehtoDepartment of Neurosurgery, Helsinki University Central Hospital, Helsinki, Finland.
Aki LaaksoDepartment of Neurosurgery, Helsinki University Central Hospital, Helsinki, Finland.
Riku KivisaariDepartment of Neurosurgery, Helsinki University Central Hospital, Helsinki, Finland.
Timo KoivistoNeurosurgery, NeuroCenter, Kuopio University Hospital, Kuopio, Finland.
Antti RonkainenNeurosurgery, NeuroCenter, Kuopio University Hospital, Kuopio, Finland.
Jaakko RinneNeurosurgery, NeuroCenter, Kuopio University Hospital, Kuopio, Finland.
Lambertus A L KiemeneyDepartment of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands ; Department for Health Evidence, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Sita H VermeulenDepartment for Health Evidence, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Mari A KaunistoInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland ; Folkhälsan Research Centre, Helsinki, Finland.
Johan G ErikssonFolkhälsan Research Centre, Helsinki, Finland ; Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland ; Department of General Practice and Primary Health Care, University of Helsinki, Helsinki, Finland ; Department of Internal Medicine, Vasa Central Hospital, Vasa, Finland ; Unit of General Practice, Helsinki University Central Hospital, Helsinki, Finland.
Arpo AromaaDepartment of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland.
Markus PerolaInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland ; Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland ; Estonian Genome Center, University of Tartu, Tartu, Estonia.
Terho LehtimäkiDepartment of Clinical Chemistry, Fimlab Laboratories, Tampere University Hospital and University of Tampere, Tampere, Finland.
Olli T RaitakariDepartment of Clinical Physiology and Nuclear Medicine, University of Turku and Turku University Hospital, Turku, Finland ; Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku and Turku University Central Hospital, Turku, Finland.
Veikko SalomaaDepartment of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland.
Murat GunelDepartment of Neurosurgery, Department of Neurobiology and Department of Genetics, Program on Neurogenetics, Howard Hughes Medical Institute, Yale School of Medicine, New Haven, Connecticut, United States of America.
Emmanouil T DermitzakisDepartment of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland.
Ynte M RuigrokUMC Utrecht Stroke Center, Department of Neurology and Neurosurgery, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, The Netherlands.
Gabriel J E RinkelUMC Utrecht Stroke Center, Department of Neurology and Neurosurgery, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, The Netherlands.
Mika NiemeläDepartment of Neurosurgery, Helsinki University Central Hospital, Helsinki, Finland.
Juha HernesniemiDepartment of Neurosurgery, Helsinki University Central Hospital, Helsinki, Finland.
Samuli RipattiInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland ; Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland ; Hjelt Institute, University of Helsinki, Helsinki, Finland.
Paul I W de BakkerDepartment of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands ; Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America ; Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America ; Department of Epidemiology, University Medical Center Utrecht, Utrecht, The Netherlands.
Aarno PalotieInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland ; Analytical and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America ; Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America ; Department of Human Genetics, The Wellcome Trust Sanger Institute, Cambridge, United Kingdom.
Juha E JääskeläinenNeurosurgery, NeuroCenter, Kuopio University Hospital, Kuopio, Finland ; Neurosurgery, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
Helsinki University Hospital · FIUniversity of Eastern Finland · FIFinnish Institute for Health and Welfare · FIUniversity Medical Center Utrecht · NLKuopio University Hospital · FIBroad Institute · USInstitute for Molecular Medicine Finland · FIRadboud University Medical Center · NLUniversity of Geneva · CHFolkhälsans Forskningscentrum · FIHoward Hughes Medical Institute · USMassachusetts General Hospital · USTampere University Hospital · FITurku University Hospital · FI

Funding

Howard Hughes Medical InstituteWellcome Trust
6 · The paper itself

Abstract

3% of the population develops saccular intracranial aneurysms (sIAs), a complex trait, with a sporadic and a familial form. Subarachnoid hemorrhage from sIA (sIA-SAH) is a devastating form of stroke. Certain rare genetic variants are enriched in the Finns, a population isolate with a small founder population and bottleneck events. As the sIA-SAH incidence in Finland is >2× increased, such variants may associate with sIA in the Finnish population. We tested 9.4 million variants for association in 760 Finnish sIA patients (enriched for familial sIA), and in 2,513 matched controls with case-control status and with the number of sIAs. The most promising loci (p<5E-6) were replicated in 858 Finnish sIA patients and 4,048 controls. The frequencies and effect sizes of the replicated variants were compared to a continental European population using 717 Dutch cases and 3,004 controls. We discovered four new high-risk loci with low frequency lead variants. Three were associated with the case-control status: 2q23.3 (MAF 2.1%, OR 1.89, p 1.42×10-9); 5q31.3 (MAF 2.7%, OR 1.66, p 3.17×10-8); 6q24.2 (MAF 2.6%, OR 1.87, p 1.87×10-11) and one with the number of sIAs: 7p22.1 (MAF 3.3%, RR 1.59, p 6.08×-9). Two of the associations (5q31.3, 6q24.2) replicated in the Dutch sample. The 7p22.1 locus was strongly differentiated; the lead variant was more frequent in Finland (4.6%) than in the Netherlands (0.3%). Additionally, we replicated a previously inconclusive locus on 2q33.1 in all samples tested (OR 1.27, p 1.87×10-12). The five loci explain 2.1% of the sIA heritability in Finland, and may relate to, but not explain, the increased incidence of sIA-SAH in Finland. This study illustrates the utility of population isolates, familial enrichment, dense genotype imputation and alternate phenotyping in search for variants associated with complex diseases.

Indexed as

Genome-Wide Association StudyChromosomes, Human, Pair 2EuropeFinlandGene FrequencyGenetic Predisposition to DiseaseGenetics, PopulationGenetic VariationHumansIntracranial AneurysmRisk FactorsStrokeSubarachnoid Hemorrhage

Identifiers

PMID24497844
PMCPMC3907358
OpenAlexW2164560068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.